2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 57.649 | 107.578 | 129.378 | 84.934 | 125.794 | 130.491 | 144.049 | 149.101 | 132.352 | 475.003 |
Total Income - EUR | 57.697 | 107.582 | 129.382 | 84.935 | 125.794 | 130.665 | 144.051 | 149.204 | 134.469 | 511.521 |
Total Expenses - EUR | 54.587 | 104.000 | 127.419 | 88.161 | 100.597 | 109.034 | 112.965 | 120.602 | 112.804 | 441.320 |
Gross Profit/Loss - EUR | 3.110 | 3.582 | 1.962 | -3.226 | 25.197 | 21.632 | 31.086 | 28.601 | 21.665 | 70.201 |
Net Profit/Loss - EUR | 2.612 | 2.556 | 676 | -4.076 | 23.940 | 20.281 | 29.469 | 26.471 | 20.269 | 57.633 |
Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioplant Srl
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 476 | 355 | 234 | 126 | 123 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 97.042 | 80.191 | 69.768 | 36.030 | 70.309 | 90.598 | 58.217 | 81.129 | 38.498 | 324.958 |
Inventories | 31.580 | 20.022 | 3.586 | 7.924 | 31.813 | 36.650 | 28.322 | 58.688 | 16.101 | 199.549 |
Receivables | 46.833 | 39.901 | 49.376 | 24.009 | 34.871 | 33.987 | 13.729 | 14.507 | 17.645 | 82.901 |
Cash | 18.629 | 20.268 | 16.807 | 4.097 | 3.625 | 19.961 | 16.166 | 7.934 | 4.751 | 42.508 |
Shareholders Funds | 1.834 | 4.370 | 4.972 | 18.554 | 42.134 | 49.970 | 57.052 | 26.517 | 46.705 | 238.659 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 95.684 | 76.175 | 65.030 | 17.602 | 28.298 | 40.628 | 1.165 | 54.612 | -8.207 | 86.299 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "4675 - 4675" | |||||||||
CAEN Financial Year |
4675
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Bioplant Srl